“While volatility still permeates the broad market, one segment has seen a fairly consistent upward trend through the bulk of the year. That segment is, of course, biotech”, notes an article cited in today’s article. What exactly are the tailwinds behind biotech – and how can both traders and investors sensing more bullishness in biotech profit from these tailwinds using ETFs? CLICK HERE.